Three separate lawsuits have been filed in the Federal Court by a total of 8 individuals against the Government of Canada alleging that the Government, through the Department of National Defence, ordered members of the Canadian Armed Forces to take an anti-malarial medication known as “Mefloquine” without adequately informing CAF Members of the severe adverse … Read More
A national class action has been certified against St. Jude Medical, Inc. and St. Jude Medical Canada, Inc. for the purpose of effecting a CAD $5 million settlement of the class action.
Howie, Sacks & Henry LLP (HSH) has revised the eligibility criteria for participation in the Canadian Essure litigation to include those women who had Essure implanted before October, 2016, and those who have undergone removal, or whose doctor has recommended removal, even if removal has not occurred yet.
If you were given an anti-malarial drug while serving in the Canadian forces you are invited to attend this free virtualevent to learn more about the forthcoming lawsuit against the DND.
175 veterans gathered at the Legion in Edmonton to learn more about the forthcoming lawsuit against the DND.
On February 10, lawyers from HSH and Waddell Phillips held their first town hall meeting at the Royal Canadian Legion 139 in Mississauga to discuss the Mefloquine lawsuit against the DND.
We would appreciate 2 minutes of your time to complete this year’s survey, and show your support for Howie, Sacks & Henry.
Canadian forces veterans met in Mississauga to learn about Mefloquine and the upcoming lawsuit against the DND.
The mefloquine lawsuit in Canada is set to help its victims receive compensation for the drug’s harmful effects and for being part of a clinical trial that didn’t follow proper procedure despite potential risks.
In this article, Valerie Lord discusses the contribution “The Bleeding Edge,” has made to the debate over faulty medical devices and reports on some recent developments announced by the FDA and Essure’s manufacturer Bayer.